Industry
Pharma & Life SciencesIn GMP Environments, Using a Superseded SOP Is Not an Error. It Is a Compliance Event.
Pharmaceutical and life sciences organizations operate under some of the most stringent document control requirements in any industry. SOPs, quality manuals, regulatory submissions and clinical protocols are version-controlled for a reason — the version matters, the approval status matters, and the effective date matters.
Keel is the Enterprise AI Context Trust Layer. It makes pharma and life sciences knowledge traceable, evidence-backed and current — so AI applications reference the approved, current version. Every time.
The Knowledge Challenge
Document Control Exists for a Reason. AI Must Respect It.
Pharma and life sciences organizations have built rigorous document control systems — QMS, EDMS, training management, regulatory archives — precisely because the version of knowledge in use matters enormously. The challenge is that AI, by default, does not understand document control. It retrieves from whatever it can access. Without a trust layer that understands revision status, approval authority and access controls, AI in a GMP environment is not just unhelpful — it is a compliance liability.
Knowledge Types in This Industry
The superseded document problem
Every pharma organization has superseded SOPs, obsolete protocols and retired specifications in its document estate. AI that retrieves from a broad document corpus — without understanding which documents are current and approved — will inevitably surface superseded content. The consequences are not theoretical.
The site and scope problem
An SOP that applies at one site may not apply at another. A procedure valid for one product or equipment model may not be valid for a different one. AI that retrieves without understanding site scope and applicability returns results that may be accurate for some contexts but wrong for this one.
The regulatory currency problem
Agency guidance changes. ICH guidelines are updated. Regional requirements diverge. An AI that supports regulatory affairs must draw from guidance that is current in the relevant market — not from a regulatory library that was last refreshed when the system was deployed.
The Trust Layer
Keel for Pharma & Life Sciences
Keel connects the document management, quality management, training and regulatory systems pharma organizations already operate — and makes the knowledge they hold trustworthy for AI. Approved procedures. Current regulatory guidance. Access-governed quality records.
What Keel Does
- —Connects QMS, document management, training management and regulatory information systems into a single trusted knowledge layer
- —Preserves revision status, effective date, approval authority and site scope for every SOP, protocol and quality document
- —Detects when an employee is attempting to access a superseded document and surfaces the current approved version
Why It Matters
- —In GMP environments, using a superseded SOP is not an error — it is a compliance event that requires investigation, CAPA and potential regulatory notification
- —AI that retrieves from an uncontrolled document corpus cannot satisfy the GMP requirement that personnel work from approved, current procedures
- —Regulatory inspectors expect firms to demonstrate control over the knowledge their AI systems draw from — not just the outputs they produce
The Outcome
- —SOP, quality and regulatory AI that draws from the current, approved version of every document — with revision and approval status preserved
- —Traceability from AI output back to the specific document, revision, effective date and approval record
- —A knowledge infrastructure that satisfies GMP documentation control requirements as a foundation for AI deployment
Trust Dimensions
SOURCE
EVIDENCE
FRESHNESS
ACCESS
CONSISTENCY
TRACEABILITY
Use Cases
AI Use Cases Keel Enables for Pharma & Life Sciences
SOP Intelligence
Operators, quality associates and manufacturing staff need immediate access to the approved, current SOP for every process — at the point of execution, in the language of the operator, for the specific equipment and site in scope.
What Trusted Context Enables
In a GMP environment, there is no acceptable margin for SOP ambiguity. Keel ensures the SOP retrieved is the approved, effective version — linked to the specific process, site and equipment. Using a superseded SOP is not an error. It is a compliance event.
Quality and Compliance
Quality teams conduct investigations, write deviations, manage CAPAs and prepare for audits. AI can accelerate this work — but it requires access to the right procedures, the right regulatory standards and the right historical records.
What Trusted Context Enables
Evidence-backed retrieval means quality AI can surface the correct regulatory requirement, the applicable SOP and the relevant precedent deviation — with source, revision and approval status preserved. Audit-ready traceability, not approximation.
Regulatory Knowledge
Regulatory affairs teams work across multiple markets, multiple submission types and an evolving body of agency guidance. AI can support regulatory strategy and submission preparation — if its knowledge of guidance documents is current.
What Trusted Context Enables
Keel connects regulatory guidance libraries — FDA, EMA, ICH and regional agencies — and tracks updates. AI-supported regulatory work draws from the guidance that is current in each market, not a static snapshot from the last indexing cycle.
Training Support
GMP training requires employees to be trained on current procedures before they perform them. AI can support training delivery, competency assessment and training record management — with significant efficiency gains.
What Trusted Context Enables
Trusted context means training AI delivers content based on the current approved procedure — not a previous version. It can also confirm that an employee has been trained on the version of the SOP that is currently in force.
Note: Keel does not make compliance determinations. It provides the trusted knowledge infrastructure that AI requires to operate responsibly in GMP and regulated life sciences environments.